Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > History Repeats

<< Previous

Bullboard Posts

Next >>

Comment by Quentin30on Nov 08, 2023 3:13pm

98 Views

Post# 35724335

RE:RE:RE:RE:RE:RE:RE:RE:History Repeats

I would gladly see ONCY go bust and know that you were holding on like a lemon all the way down Azzak. In fact that makes me all giddy. I didn't epect a keyboard warrior like you to accept my challenge...

ONCY or CRPR - buy today to see who makes the most by 31-Dec...

Now get off the sole of my boot would ya.

<< Previous

Bullboard Posts

Next >>

How to decrease sector risk by owning hundreds of mineral assets